Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT06597994
NA
Augmenting Urinary Reflex Activity: Study 3
Sponsor: Amber Therapeutics Ltd
View on ClinicalTrials.gov
Summary
AURA-3 study (Augmenting Urinary Reflex Activity Study 3) is a single arm, short-duration (8 month) cohort follow up study of preceding interventional medical device study, AURA-2.
Official title: Therapy Optimisation Study of Adaptive Pudendal Neuromodulation in Women With Urinary Incontinence Implanted With the Amber UI System.
Key Details
Gender
FEMALE
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
11
Start Date
2025-01-15
Completion Date
2025-12-08
Last Updated
2026-10-27
Healthy Volunteers
No
Conditions
Interventions
DEVICE
Amber UI system
Upgrade of Amber UI system recharge accessories and system firmware
Locations (1)
University Hospital Antwerp
Antwerp, Antwerp, Belgium